Works matching DE "ISOCITRATE dehydrogenase"

Results: 1422

Analysis of IDH1 and IDH2 mutations as causes of the hypermethylator phenotype in colorectal cancer.

Published in:

Journal of Pathology, 2025, v. 267, n. 1, p. 40, doi. 10.1002/path.6446

By:

Ward, Joseph C;
Morgan, Melissa;
Wood, James;
Woolley, Connor;
de Menezes, Albert Antao Nobre;
Finch, Alina;
Sherwood, Kitty;
Huang, Qiwen;
Henry, Chloe S;
Fernández‐Tajes, Juan;
Soriano, Ignacio;
Thorn, Steve;
Legge, Isabelle;
McCullagh, James;
Kerr, David;
Kerr, Rachel;
Hejmadi, Rahul K;
Arends, Mark J;
Adams, Richard;
Bach, Simon

Publication type:

Article

SKP2 ubiquitylation modifies IDH1 to regulate hepatoblastoma cell cycle and glucose metabolism.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14644-5

By:

Yu, Pengxiang;
Li, Jiarong;
Feng, Wei;
Lei, Tao;
Jia, Wen;
He, Yun;
Bi, Yang

Publication type:

Article

Phenotype augmentation using generative AI for isocitrate dehydrogenase mutation prediction in glioma.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-14477-z

By:

Jung, Ha Kyung;
Choi, Changyong;
Park, Ji Eun;
Park, Seo Young;
Lee, Jae Ho;
Kim, Namkug;
Kim, Ho Sung

Publication type:

Article

Immunohistochemical analysis of IDH1, ATRX, p53, and Ki-67 in glioblastoma and diffuse infiltrative glioma: therapeutic and prognostic correlation.

Published in:

Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2025, v. 82, n. 7, p. 413, doi. 10.2298/VSP241008042H

By:

Hasbay, Bermal;
Kayaselçuk, Fazilet;
Süner, Halil İbrahim;
Tufan, Kadir

Publication type:

Article

Age-Related Effects of Orthovanadate Nanoparticles Involve Activation of GSH-Dependent Antioxidant System in Liver Mitochondria.

Published in:

Biological Trace Element Research, 2021, v. 199, n. 2, p. 649, doi. 10.1007/s12011-020-02196-7

By:

Nikitchenko, Yuri V.;
Klochkov, Vladimir K.;
Kavok, Nataliya S.;
Karpenko, Nina A.;
Yefimova, Svetlana L.;
Nikitchenko, Irina V.;
Bozhkov, Anatoly I.

Publication type:

Article

NADP+‐dependent isocitrate dehydrogenase isozymes from a psychrotrophic bacterium, Psychrobacter sp. strain 13A.

Published in:

Journal of Basic Microbiology, 2021, v. 61, n. 7, p. 612, doi. 10.1002/jobm.202000720

By:

Komura, Tatsuhiko;
Takada, Yasuhiro

Publication type:

Article

Point mutation (R153H or R153C) in Escherichia coli isocitrate dehydrogenase: Biochemical characterization and functional implication.

Published in:

Journal of Basic Microbiology, 2017, v. 57, n. 1, p. 41, doi. 10.1002/jobm.201600096

By:

Song, Ping;
Li, Shan;
Wu, Yatao;
Lv, Changqi;
Wang, Peng;
Zhu, Guoping

Publication type:

Article

Two isocitrate dehydrogenases from a plant pathogen Xanthomonas campestris pv. campestris 8004. Bioinformatic analysis, enzymatic characterization, and implication in virulence.

Published in:

Journal of Basic Microbiology, 2016, v. 56, n. 9, p. 975, doi. 10.1002/jobm.201500648

By:

Lv, Changqi;
Wang, Peng;
Wang, Wencai;
Su, Ruirui;
Ge, Yadong;
Zhu, Youming;
Zhu, Guoping

Publication type:

Article

Prognostic impact of second surgical resection in IDH wildtype recurrent glioblastoma following chemo-radiation therapy: a propensity score analysis cohort study.

Published in:

Journal of Neuro-Oncology, 2025, v. 174, n. 3, p. 789, doi. 10.1007/s11060-025-05096-9

By:

Bertolini, Giacomo;
Trombini, Tommaso;
Zenesini, Corrado;
Mazza, Stefania;
Dascola, Isabella;
Pavarani, Antonio;
Michiara, Maria;
Ceccon, Giovanni;
Peluso, Andrea;
Calamo Specchia, Francesco Maria;
Crafa, Pellegrino;
Menozzi, Roberto;
Giombelli, Ermanno

Publication type:

Article

Prognostic and clinical significance of contrast enhancement in WHO grade 2 oligodendrogliomas.

Published in:

Journal of Neuro-Oncology, 2025, v. 172, n. 2, p. 481, doi. 10.1007/s11060-024-04929-3

By:

Zhao, Xuzhe;
Zhang, Yutao;
Wang, Yonggang;
Ren, Xiaohui;
Zhang, Xiaokang;
Wan, Haibin;
Li, Ming;
Zhou, Dabiao

Publication type:

Article

Patient-derived glioma organoids real time identification of IDH mutation, 1p/19q-codeletion and CDKN2A/B homozygous deletion with differential ion mobility spectrometry.

Published in:

Journal of Neuro-Oncology, 2025, v. 171, n. 3, p. 691, doi. 10.1007/s11060-024-04891-0

By:

Hermelo, Ismaïl;
Haapala, Ilkka;
Mäkelä, Meri;
Jacome Sanz, Dafne;
Kontunen, Anton;
Karjalainen, Markus;
Müller, Philipp;
Lehtimäki, Kai;
Nykter, Matti;
Frösén, Juhana;
Haapasalo, Hannu;
Roine, Antti;
Oksala, Niku;
Nordfors, Kristiina;
Vehkaoja, Antti;
Haapasalo, Joonas

Publication type:

Article

A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design.

Published in:

Journal of Neuro-Oncology, 2025, v. 171, n. 2, p. 373, doi. 10.1007/s11060-024-04852-7

By:

Wetzel, Ethan A.;
Nohman, Amin I.;
Hsieh, Annie L.;
Reuss, David;
Unterberg, Andreas W.;
Eyüpoglu, Ilker Y.;
Hua, Lingyang;
Youssef, Gilbert;
Wen, Patrick Y.;
Cahill, Daniel P.;
Jungk, Christine;
Juratli, Tareq A.;
Miller, Julie J.

Publication type:

Article

Association of preoperative seizures with reduced expression of soluble CD163, an M2 macrophage marker, in the cerebrospinal fluid in isocitrate dehydrogenase wild-type glioblastoma.

Published in:

Journal of Neuro-Oncology, 2025, v. 171, n. 1, p. 95, doi. 10.1007/s11060-024-04837-6

By:

Yamanishi, Shunsuke;
Nagashima, Hiroaki;
Tanaka, Kazuhiro;
Uno, Takiko;
Ikeuchi, Yusuke;
Iwahashi, Hirofumi;
Hashiguchi, Mitsuru;
Horii, Shintaro;
Itoh, Tomoo;
Muragaki, Yoshihiro;
Sasayama, Takashi

Publication type:

Article

Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign.

Published in:

Journal of Neuro-Oncology, 2024, v. 170, n. 2, p. 429, doi. 10.1007/s11060-024-04794-0

By:

Onishi, Shumpei;
Yamasaki, Fumiyuki;
Akiyama, Yuji;
Kawahara, Daisuke;
Amatya, Vishwa Jeet;
Yonezawa, Ushio;
Taguchi, Akira;
Ozono, Iori;
Khairunnisa, Novita Ikbar;
Takeshima, Yukio;
Horie, Nobutaka

Publication type:

Article

The effects of BMP2 and the mechanisms involved in the invasion and angiogenesis of IDH1 mutant glioma cells.

Published in:

Journal of Neuro-Oncology, 2024, v. 170, n. 1, p. 161, doi. 10.1007/s11060-024-04789-x

By:

Xu, Hui;
Cao, Yu;
Ruan, Jianqiao;
Wang, Fei;
He, Yuhong;
Yang, Lina;
Yu, Tian;
Du, Fang;
Zhang, Ningmei;
Cao, Xiangmei

Publication type:

Article

Multi-pool chemical exchange saturation transfer MRI in glioma grading, molecular subtyping and evaluating tumor proliferation.

Published in:

Journal of Neuro-Oncology, 2024, v. 169, n. 2, p. 287, doi. 10.1007/s11060-024-04729-9

By:

Zhu, Hongquan;
Li, Yuanhao;
Ding, Yuejie;
Liu, Yufei;
Shen, Nanxi;
Xie, Yan;
Yan, Su;
Liu, Dong;
Zhang, Xiaoxiao;
Li, Li;
Zhu, Wenzhen

Publication type:

Article

Results from a first-in-human phase I safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma.

Published in:

Journal of Neuro-Oncology, 2024, v. 168, n. 2, p. 225, doi. 10.1007/s11060-024-04647-w

By:

Doron, Omer;
Wong, Tamika;
Ablyazova, Faina;
Singha, Souvik;
Cavallaro, Julianna;
Ben-Shalom, Netanel;
D'Amico, Randy S.;
Harshan, Manju;
McKeown, Amy;
Zlochower, Avraham;
Langer, David J.;
Boockvar, John A.

Publication type:

Article

The diagnostic efficiency of integration of 2HG MRS and IVIM versus individual parameters for predicting IDH mutation status in gliomas in clinical scenarios: A retrospective study.

Published in:

Journal of Neuro-Oncology, 2024, v. 167, n. 2, p. 305, doi. 10.1007/s11060-024-04609-2

By:

Yu, Meimei;
Ge, Ying;
Wang, Zixuan;
Zhang, Yang;
Hou, Xinyi;
Chen, Hongyan;
Chen, Xuzhu;
Ji, Nan;
Li, Xin;
Shen, Huicong

Publication type:

Article

Clinical and molecular determinants of bleeding-related adverse outcomes in high-grade glioma.

Published in:

Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 569, doi. 10.1007/s11060-024-04574-w

By:

Dasgupta, Pushan;
Rousseau, Justin F.

Publication type:

Article

GammaTile® (GT) as a brachytherapy platform for rapidly proliferating glioblastomas: from case series to clinical trials.

Published in:

Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 441, doi. 10.1007/s11060-023-04545-7

By:

Yekula, Anudeep;
Gessler, Dominic J.;
Ferreira, Clara;
Shah, Rena;
Reynolds, Margaret;
Dusenbery, Kathryn;
Chen, Clark C.

Publication type:

Article

An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma.

Published in:

Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 557, doi. 10.1007/s11060-023-04544-8

By:

Tanaka, Toshihide;
Tamura, Ryota;
Takei, Jun;
Morimoto, Yukina;
Teshigawara, Akihiko;
Yamamoto, Yohei;
Imai, Ryotaro;
Kuranari, Yuki;
Tohmoto, Kyoichi;
Hasegawa, Yuzuru;
Akasaki, Yasuharu;
Murayama, Yuichi;
Miyake, Keisuke;
Sasaki, Hikaru

Publication type:

Article

Signal-transducing adaptor protein 1 (STAP1) in microglia promotes the malignant progression of glioma.

Published in:

Journal of Neuro-Oncology, 2023, v. 164, n. 1, p. 127, doi. 10.1007/s11060-023-04390-8

By:

Yang, Xinyu;
Ji, Chunxia;
Qi, Ying;
Huang, Jianhan;
Hu, Lang;
Zhou, Yuan;
Zou, Liping;
Xia, Yi;
Tan, Feng;
Yao, Yu;
Chen, Di

Publication type:

Article

Long-term follow up of patients with WHO grade 2 oligodendroglioma.

Published in:

Journal of Neuro-Oncology, 2023, v. 164, n. 1, p. 65, doi. 10.1007/s11060-023-04368-6

By:

Carstam, Louise;
Latini, Francesco;
Solheim, Ole;
Bartek Jr., Jiri;
Pedersen, Lars K.;
Zetterling, Maria;
Beniaminov, Stanislav;
Sjåvik, Kristin;
Ryttlefors, Mats;
Jensdottir, Margret;
Rydenhag, Bertil;
Smits, Anja;
Jakola, Asgeir S.

Publication type:

Article

Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status.

Published in:

Journal of Neuro-Oncology, 2023, v. 163, n. 2, p. 339, doi. 10.1007/s11060-023-04342-2

By:

Tini, Paolo;
Yavoroska, Mariya;
Mazzei, Maria Antonietta;
Miracco, Clelia;
Pirtoli, Luigi;
Tomaciello, Miriam;
Marampon, Francesco;
Minniti, Giuseppe

Publication type:

Article

Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas.

Published in:

Journal of Neuro-Oncology, 2023, v. 162, n. 3, p. 481, doi. 10.1007/s11060-022-04218-x

By:

Wollring, Michael M.;
Werner, Jan-Michael;
Ceccon, Garry;
Lohmann, Philipp;
Filss, Christian P.;
Fink, Gereon R.;
Langen, Karl-Josef;
Galldiks, Norbert

Publication type:

Article

Conventional and emerging treatments of astrocytomas and oligodendrogliomas.

Published in:

Journal of Neuro-Oncology, 2023, v. 162, n. 3, p. 471, doi. 10.1007/s11060-022-04216-z

By:

Kessler, Tobias;
Ito, Jakob;
Wick, Wolfgang;
Wick, Antje

Publication type:

Article

Proton radiotherapy in the treatment of IDH-mutant diffuse gliomas: an early experience from shanghai proton and heavy ion center.

Published in:

Journal of Neuro-Oncology, 2023, v. 162, n. 3, p. 503, doi. 10.1007/s11060-022-04202-5

By:

Qiu, Xianxin;
Gao, Jing;
Hu, Jiyi;
Yang, Jing;
Hu, Weixu;
Huang, Qingting;
Zhang, Haojiong;
Lu, Jiade J.;
Kong, Lin

Publication type:

Article

Isocitrate-dehydrogenase-mutant lower grade glioma in elderly patients: treatment and outcome in a molecularly characterized contemporary cohort.

Published in:

Journal of Neuro-Oncology, 2023, v. 161, n. 3, p. 605, doi. 10.1007/s11060-022-04230-1

By:

Dao Trong, P.;
Gluszak, M.;
Reuss, D.;
von Deimling, A.;
Wick, A.;
König, L.;
Debus, J.;
Herold-Mende, C.;
Unterberg, A.;
Jungk, C.

Publication type:

Article

Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year period.

Published in:

Journal of Neuro-Oncology, 2022, v. 160, n. 3, p. 535, doi. 10.1007/s11060-022-04136-y

By:

Svenjeby, Caroline;
Carstam, Louise;
Werlenius, Katja;
Bontell, Thomas Olsson;
Rydén, Isabelle;
Jacobsson, Julia;
Dénes, Anna;
Jakola, Asgeir S.;
Corell, Alba

Publication type:

Article

Assessment of radiographic and prognostic characteristics of programmed death-ligand 1 expression in high-grade gliomas.

Published in:

Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 463, doi. 10.1007/s11060-022-04165-7

By:

Ohno, Makoto;
Kitano, Shigehisa;
Satomi, Kaishi;
Yoshida, Akihiko;
Miyakita, Yasuji;
Takahashi, Masamichi;
Yanagisawa, Shunsuke;
Tamura, Yukie;
Ichimura, Koichi;
Narita, Yoshitaka

Publication type:

Article

Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3.

Published in:

Journal of Neuro-Oncology, 2022, v. 160, n. 1, p. 149, doi. 10.1007/s11060-022-04128-y

By:

Weller, Jonathan;
Katzendobler, Sophie;
Blobner, Jens;
Thiele, Frederic;
Becker, Hannes;
Quach, Stefanie;
Egensperger, Rupert;
Niyazi, Maximilian;
Suchorska, Bogdana;
Thon, Niklas;
Weller, Michael;
Tonn, Joerg-Christian

Publication type:

Article

Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of neuropathology in the management of progressive glioblastoma in adults.

Published in:

Journal of Neuro-Oncology, 2022, v. 158, n. 2, p. 179, doi. 10.1007/s11060-022-04005-8

By:

Goodman, Abigail L.;
Velázquez Vega, José E.;
Glenn, Chad;
Olson, Jeffrey J.

Publication type:

Article

Stereotactic radiosurgery for IDH wild type glioblastoma: an international, multicenter study.

Published in:

Journal of Neuro-Oncology, 2021, v. 155, n. 3, p. 343, doi. 10.1007/s11060-021-03883-8

By:

Bunevicius, Adomas;
Pikis, Stylianos;
Kondziolka, Douglas;
Patel, Dev N.;
Bernstein, Kenneth;
Sulman, Erik P.;
Lee, Cheng-chia;
Yang, Huai-che;
Delabar, Violaine;
Mathieu, David;
Cifarelli, Christopher P.;
Arsanious, David E.;
Dahshan, Basem A.;
Weir, Joshua S.;
Speckter, Herwin;
Mota, Angel;
Tripathi, Manjul;
Kumar, Narendra;
Warnick, Ronald E.;
Peker, Selcuk

Publication type:

Article

Radiomics-based prediction of multiple gene alteration incorporating mutual genetic information in glioblastoma and grade 4 astrocytoma, IDH-mutant.

Published in:

Journal of Neuro-Oncology, 2021, v. 155, n. 3, p. 267, doi. 10.1007/s11060-021-03870-z

By:

Sohn, Beomseok;
An, Chansik;
Kim, Dain;
Ahn, Sung Soo;
Han, Kyunghwa;
Kim, Se Hoon;
Kang, Seok-Gu;
Chang, Jong Hee;
Lee, Seung-Koo

Publication type:

Article

Tumor location-based classification of surgery-related language impairments in patients with glioma.

Published in:

Journal of Neuro-Oncology, 2021, v. 155, n. 2, p. 143, doi. 10.1007/s11060-021-03858-9

By:

Fang, Shengyu;
Liang, Yuchao;
Li, Lianwang;
Wang, Lei;
Fan, Xing;
Wang, Yinyan;
Jiang, Tao

Publication type:

Article

Repeated superselective intraarterial bevacizumab after blood brain barrier disruption for newly diagnosed glioblastoma: a phase I/II clinical trial.

Published in:

Journal of Neuro-Oncology, 2021, v. 155, n. 2, p. 117, doi. 10.1007/s11060-021-03851-2

By:

Patel, Nitesh V.;
Wong, Tamika;
Fralin, Sherese R.;
Li, Mona;
McKeown, Amy;
Gruber, Deborah;
D'Amico, Randy S.;
Patsalides, Athos;
Tsiouris, Apostolos;
Stefanov, Dimitre G.;
Flores, Oscar;
Zlochower, Avraham;
Filippi, Christopher G.;
Ortiz, Rafael;
Langer, David J.;
Boockvar, John A.

Publication type:

Article

IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat.

Published in:

Journal of Neuro-Oncology, 2021, v. 154, n. 2, p. 159, doi. 10.1007/s11060-021-03829-0

By:

Sears, Thomas K.;
Horbinski, Craig M.;
Woolard, Kevin D.

Publication type:

Article

PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma.

Published in:

Journal of Neuro-Oncology, 2021, v. 153, n. 1, p. 153, doi. 10.1007/s11060-021-03755-1

By:

Dono, Antonio;
Mitra, Sonali;
Shah, Mauli;
Takayasu, Takeshi;
Zhu, Jay-Jiguang;
Tandon, Nitin;
Patel, Chirag B.;
Esquenazi, Yoshua;
Ballester, Leomar Y.

Publication type:

Article

Preferential tumor localization in relation to 18F-FDOPA uptake for lower‐grade gliomas.

Published in:

Journal of Neuro-Oncology, 2021, v. 152, n. 3, p. 573, doi. 10.1007/s11060-021-03730-w

By:

Tatekawa, Hiroyuki;
Uetani, Hiroyuki;
Hagiwara, Akifumi;
Yao, Jingwen;
Oughourlian, Talia C.;
Ueda, Issei;
Raymond, Catalina;
Lai, Albert;
Cloughesy, Timothy F.;
Nghiemphu, Phioanh L.;
Liau, Linda M.;
Bahri, Shadfar;
Pope, Whitney B.;
Salamon, Noriko;
Ellingson, Benjamin M.

Publication type:

Article

Fluid attenuation in non‐contrast‐enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in Glioblastoma.

Published in:

Journal of Neuro-Oncology, 2021, v. 152, n. 3, p. 523, doi. 10.1007/s11060-021-03720-y

By:

Patel, Sohil H.;
Batchala, Prem P.;
Muttikkal, Thomas J. Eluvathingal;
Ferrante, Sergio S.;
Patrie, James T.;
Fadul, Camilo E.;
Schiff, David;
Lopes, M. Beatriz;
Jain, Rajan

Publication type:

Article

Functional connectivity of the default mode, dorsal attention and fronto-parietal executive control networks in glial tumor patients.

Published in:

Journal of Neuro-Oncology, 2021, v. 152, n. 2, p. 347, doi. 10.1007/s11060-021-03706-w

By:

Tordjman, Mickael;
Madelin, Guillaume;
Gupta, Pradeep Kumar;
Cordova, Christine;
Kurz, Sylvia C.;
Orringer, Daniel;
Golfinos, John;
Kondziolka, Douglas;
Ge, Yulin;
Wang, Ruoyu Luie;
Lazar, Mariana;
Jain, Rajan

Publication type:

Article

The role of neuropathology in the management of newly diagnosed glioblastoma: a systematic review and evidence-based clinical practice guideline.

Published in:

Journal of Neuro-Oncology, 2020, v. 150, n. 2, p. 143, doi. 10.1007/s11060-020-03616-3

By:

Velázquez Vega, José E.;
Brat, Daniel J.;
Ryken, Timothy C.;
Olson, Jeffrey J.

Publication type:

Article

Automated apparent diffusion coefficient analysis for genotype prediction in lower grade glioma: association with the T2-FLAIR mismatch sign.

Published in:

Journal of Neuro-Oncology, 2020, v. 149, n. 2, p. 325, doi. 10.1007/s11060-020-03611-8

By:

Aliotta, Eric;
Dutta, Sunil W.;
Feng, Xue;
Tustison, Nicholas J.;
Batchala, Prem P.;
Schiff, David;
Lopes, M. Beatriz;
Jain, Rajan;
Druzgal, T. Jason;
Mukherjee, Sugoto;
Patel, Sohil H.

Publication type:

Article

Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomas.

Published in:

Journal of Neuro-Oncology, 2020, v. 149, n. 2, p. 337, doi. 10.1007/s11060-020-03613-6

By:

Tatekawa, Hiroyuki;
Hagiwara, Akifumi;
Uetani, Hiroyuki;
Yao, Jingwen;
Oughourlian, Talia C.;
Bahri, Shadfar;
Wang, Chencai;
Raymond, Catalina;
Lai, Albert;
Cloughesy, Timothy F.;
Nghiemphu, Phioanh L.;
Liau, Linda M.;
Pope, Whitney B.;
Salamon, Noriko;
Ellingson, Benjamin M.

Publication type:

Article

Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation.

Published in:

Journal of Neuro-Oncology, 2020, v. 147, n. 1, p. 1, doi. 10.1007/s11060-020-03394-y

By:

Ferreira, Monica Sofia Ventura;
Sørensen, Mia Dahl;
Pusch, Stefan;
Beier, Dagmar;
Bouillon, Anne-Sophie;
Kristensen, Bjarne Winther;
Brümmendorf, Tim Henrik;
Beier, Christoph Patrick;
Beier, Fabian

Publication type:

Article

Extracellular glutamate and IDH1R132H inhibitor promote glioma growth by boosting redox potential.

Published in:

Journal of Neuro-Oncology, 2020, v. 146, n. 3, p. 427, doi. 10.1007/s11060-019-03359-w

By:

Tiburcio, Patricia D. B.;
Gillespie, David L.;
Jensen, Randy L.;
Huang, L. Eric

Publication type:

Article

Prediction of lower-grade glioma molecular subtypes using deep learning.

Published in:

Journal of Neuro-Oncology, 2020, v. 146, n. 2, p. 321, doi. 10.1007/s11060-019-03376-9

By:

Matsui, Yutaka;
Maruyama, Takashi;
Nitta, Masayuki;
Saito, Taiichi;
Tsuzuki, Shunsuke;
Tamura, Manabu;
Kusuda, Kaori;
Fukuya, Yasukazu;
Asano, Hidetsugu;
Kawamata, Takakazu;
Masamune, Ken;
Muragaki, Yoshihiro

Publication type:

Article

Increased 14C-acetate accumulation in IDH-mutated human glioblastoma: implications for detecting IDH-mutated glioblastoma with 11C-acetate PET imaging.

Published in:

Journal of Neuro-Oncology, 2019, v. 145, n. 3, p. 441, doi. 10.1007/s11060-019-03322-9

By:

Koyasu, Sho;
Shimizu, Yoichi;
Morinibu, Akiyo;
Saga, Tsuneo;
Nakamoto, Yuji;
Togashi, Kaori;
Harada, Hiroshi

Publication type:

Article

Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastoma.

Published in:

Journal of Neuro-Oncology, 2019, v. 145, n. 2, p. 321, doi. 10.1007/s11060-019-03298-6

By:

Hoffman, Daniel I.;
Abdullah, Kalil G.;
McCoskey, Makayla;
Binder, Zev A.;
O'Rourke, Donald M.;
Desai, Arati S.;
Nasrallah, MacLean P.;
Bigdeli, Ashkan;
Morrissette, Jennifer J. D.;
Brem, Steven;
Bagley, Stephen J.

Publication type:

Article

Increased intratumoral infiltration in IDH wild-type lower-grade gliomas observed with diffusion tensor imaging.

Published in:

Journal of Neuro-Oncology, 2019, v. 145, n. 2, p. 257, doi. 10.1007/s11060-019-03291-z

By:

Aliotta, Eric;
Batchala, Prem P.;
Schiff, David;
Lopes, Beatriz M.;
Druzgal, Jason T.;
Mukherjee, Sugoto;
Patel, Sohil H.

Publication type:

Article